NCT00398710 2018-03-15
A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia
AEterna Zentaris
Phase 2 Completed
Clinical Trials
9 trialsNCT00391560 2018-03-14
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
AEterna Zentaris
Phase 2 Completed
NCT00398879 2018-03-14
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
AEterna Zentaris
Phase 2 Completed
NCT00389077 2018-03-07
Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas
AEterna Zentaris
Phase 2 Completed
NCT00401388 2018-03-07
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
AEterna Zentaris
Phase 2 Completed
NCT00448721 2018-03-01
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
AEterna Zentaris
Phase 2 Completed
NCT00375791 2018-02-28
Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
AEterna Zentaris
Phase 2 Completed
NCT00455559 2018-02-22
Ph II Study of Perifosine Plus Gleevec for Patients With GIST
AEterna Zentaris
Phase 2 Completed
NCT00498966 2018-02-05
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
AEterna Zentaris
Phase 2 Completed